23 - 25 March 2015

Suntec Singapore Convention & Exhibition Centre,

Singapore

Navigating the future of Asias

biopharmaceutical industry

www.terrapinn.com/biopharmaasia

The Big Picture

Asias biopharmaceutical industry is entering a period of opportunity; the need for industrial
collaborations to foster innovation and change has never been more important.
The 8th BioPharma Asia Convention is the most prestigious regional gathering of pharma and
biotech executives, investors, academics and solution providers. It is the perfect platform for
companies to launch new products, gain valuable insights from key industry stakeholders and
maintain relationships with their clients.

For more information about how you can get involved in this event,
contact Kenneth Lai on +65 6322 2792 or email kenneth.lai@terrapinn.com

Premium
Keynote

Tuesday 24 March 2015

9.00am

Combating diseases with

disruptive mRNA technology

Stephan Bancel
President & Founding Chief
Executive Officer
Moderna Therapeutics, USA

Stephan joined Moderna in 2011 when it was a one employee and

one patent company after the technology behind messenger RNA
Therapeutics was described to him. He has since assembled a worldclass team and raised the companys financing. Previously he was CEO
of bioMrieux. He led the company through 10 successful acquisitions in
the U.S., Europe, and Asia/Pacific without needing new capital. During
that time, the companys market capitalization nearly doubled. Stephan
is named as an inventor on over 45 patent filings. He was elected a 2009
Young Global Leader; best CEO for investor relations in France in 2009
and was ranked the number one CEO in the biotech sector.

Event at a Glance
Book before
BioPharma Asia Convention 2015 brings together stakeholders
from across the whole biopharmaceutical value chain.

17th October
to save

This event provides ample opportunities to meet, learn and

network with industry leaders from clinical trials, supply
chain and manufacturing. This event also presents an array
of partnering and investment opportunities. Key industry
figureheads will review the current Asian market and present
ways to leverage on its business opportunities.

SGD 810

Let Singapore Immunology Network (SIgN) and Stem Cell and Cancer
Institute bring you through their groundbreaking research in human
immunology, battling health problems, and oncology.

With over 80 exhibition booths showcasing the latest R&D, clinical

trials, manufacturing, packaging options and lots more, we promise
youll have a field day exploring the best solutions for your business.

Gain fresh external perspectives on implementing innovation in the

biopharmaceutical industry and challenge the opinions of key industry
leaders.

Sit in for a holistic learning experience with regional colleagues.

Hear real life examples of solutions being implemented to overcome
common industry challenges.

Pre-Conference
Workshop Day

Superstar Keynote Sessions

SPEED NETWORKING
MARKET ACCESS

Morning workshops

SPEED NETWORKING

MERGER & ACQUISITION

ORPHAN DRUGS

LICENSING

COMPLIANCE

CLINICAL DESIGN

DATA MANAGEMENT

CLINICAL
DEVELOPMENT

REGULATIONS

SUPPLY CHAIN
MANAGEMENT

GENERICS

TRANSLATIONAL
MEDICINE

CELL & GENE

THERAPY

COLD CHAIN

DOWNSTREAM
PROCESSING

QUALITY BY DESIGN
(QbD)

BIOSIMILARS

CELL CULTURE

VACCINES

Networking luncheons

Keynote sessions

Case-study presentations

Afternoon workshops

Roundtable discussions

Roundtable discussions

Site tours

BioPharma Asia
Industry Awards dinner

Panel discussions
Exhibition

Welcome cocktail
reception

1-2-1 Partnering
Asian Biotech Showcase
Freemium Conference Agenda

Explore opportunities for partnerships and licensing deals with Asias

most promising biotechs and learn more about the clinical potential of
their pipelines.

Learn more about the latest technologies and trends in biopharma

manufacturing, supply chain, pharma trials and R&D.

Engage in interactive, themed discussions around prevalent industry

trends and challenges. Share your knowledge and enrich yourself with
different perspectives from your global counterparts.

Continue thought-provoking discussions with face-to-face meetings

through the numerous networking opportunities both on-line and
on-site!

KEY SPEAKERS

Nathan
Kothandaraman
Director, Market
Access & Government
Affairs,
Janssen, Malaysia

Shun Jin

James Garner

Pankaj Monga

Director, Regulatory
Affairs

Head, Unit
Development
Operations, Asia R&D

Director, Brand
Protection, Asia

Takeda
Pharmaceuticals,
Singapore

Sanofi, Singapore

Johnson & Johnson,

India

Sanjit Singh
Lamba
Managing Director,
President-Global Brands
Unit, Head-Global,
Procurement Strategy

Eisai Knowledge
Centre, India

Matsumoto Jun

Xu Wei

Rajnish Narula

Kiyean Nam

David Lawrence

Principal Reviewer,
Office of Cellular
and Tissue-based
Products

Chief Operating Officer

Director, Production

Chief Executive Officer

Chief Executive Officer

Sotio, China

Pfizer, Singapore

Qurient
Therapeutics, South
Korea

Sentinext
Therapeutics,
Malaysia

Terence Eng

Sagnik Sengupta

Jeroze Dalal

Debashis Basu

Wei-Kuang Chi

Manager, Regional
Demand & Supply
Planning

General Manager,
Distribution

General Manager,
Clinical Operations

Head, Supply Chain

Distinguished Scientist,
Bioengineering Group

Novartis, Singapore

Bharat Serums and

Vaccines, India

GlaxoSmithKline,
India

Pradip M Patel

Peter French

Li Long

Zami Aberman

Kensei Tsuzaka

Vice President & Head,

Vaccine (Operations &
Project)

Chief Executive Officer

Chief Executive Officer

Chief Executive Officer

Chief Executive Officer

Benitec Biopharma,
Australia

KBP Biosciences,
China

Pluristem, Israel

Kaytee Bio, Japan

Pharmaceutical and
Medical Devices
Agency (PMDA),
Japan

Zydus Cadila, India

Roche Diagnostics,
India

Development Centre
for Biotechnology,
Taiwan

Premium
Conference
08:45

Organisers welcome remarks

08:50

Chairmans opening address

09:00

09:30

Combating diseases with disruptive mRNA technology

Stephan Bancel, President & Founding Chief Executive Officer, Moderna Therapeutics, USA
Making peoples lives better through change, innovation & growth
David Gallon, Director, Strategic Insight & Innovation, Toyota Financial Services, USA
Speed networking

10:30

Morning refreshments I Exhibition visit I 1-to-1 partnering

TRACK 1

TRACK 2

TRACK 3

TRACK 4

MARKET ACCESS

CELL CULTURE

CLINICAL DEVELOPMENT

GENERICS

Pricing strategies in emerging markets

Xiang Yang Zhu, Chief Executive

Officer, Huaota Biopharm, China

Novel cell line development strategies

for monoclonal antibody production

Government initiatives to develop

Malaysia as a clinical hub

Outsourcing a generics supply chain

Pik Pin Goh, Director, Clinical

Research Centre, Ministry of
Health, Malaysia

Rajiv Bindage, Director, External

Supply, Pfizer, India

Role of academic research

organisations in clinical trials

Patent expiry of generics

Leena Menghaney, Head, Access
Campaign, South Asia, Doctors
Without Borders/Mdecins Sans
Frontires, India

Chi Wei-Kuang, Distinguished

Scientist, Bioengineering Group,
Development Centre for
Biotechnology, Taiwan

Yee Leong Teoh, Chief Executive

Officer, Singapore Clinical Research
Institute (SCRI), Singapore

11:40

Preparing your product for Malaysia in

the absence of reimbursement policies

Stable cell lines for higher expression

level of biotherapeutics

Cell banking methods to produce highquality biologic products

Is India still a desired destination for

clinical trials?

Cost-containment measures in China

Amol Kataria, Research Associate,

Cell Line Development, Intas
Biopharmaceuticals, India

Jeroze Dalal, General Manager,

Clinical Operations, GlaxoSmithKline,
India

Preventing counterfeit

12:00

11:20

11:00

10:00

Sponsored slot

Sponsored slot

Sponsored slot

Sponsored slot

Nathan Kothandaraman, Director,

Market Access & Government Affairs,
Janssen, Malaysia

12:20

Roundtable discussions
Table A: Pricing and reimbursement
strategies in Japan, Korea and Australia

Table A: Hybrid manufacturing for cell

culture production

Table A: Clinical outsourcing models in

Japan, Korea and Australia

Table A: Reverse logistics

Table B: Pricing and reimbursement

strategies in China and India

Table B: Raw material testing &

handling

Table B: Clinical outsourcing models in

China and India

Table B: CMO selection in Asia

Table C: Pricing and reimbursement

strategies in Singapore & Malaysia

Table C: Decontamination technologies

for cell culture growth

Table C: Clinical outsourcing models in

Singapore & Malaysia

Table C: Pricing of generics

13:00

Networking luncheon I Exhibition visit I 1-to-1 partnering

Day One
Tuesday 24 March 2015

14:50

14:30

MERGER & ACQUISITION

DOWNSTREAM PROCESSING

Panel discussion: Cashing-in on Asias

promising biotechs

Non-column purification to improve

process economy

Kiyean Nam, Chief Executive Officer,

Qurient, South Korea

Pete Gagnon, Senior Research

Technology Specialist, Downstream
Processing Group, Bioprocess
Technology Institute, Agency for
Science, Technology and Research
(A*STAR), Singapore

Allen Baharaff, Chief Executive

Officer, Galmed Pharmaceuticals,
Israel
James Huang, Managing Partner,
Kleiner Perkins Caufield Byers
(KPCB), China
Amit Kakar, Head, Healthcare, Asia,
Avenue Capital Group, Hong Kong

Panel discussion: Defining the

capabilities and limits for single-use
technology

DATA MANAGEMENT

CELL & GENE THERAPY

Big data for gene sequencing

Gene therapies for reverse vaccine

development

Web-based crowdsourcing

Natural killer cells for oncology

treatments

15:10

Pradip M Patel, Vice President & Head

Vaccine (Operations & Project), Zydus
Cadila, India

Academics priorities in industrial

collaboration

Steven S. Lee, Global Head, Technical

Operations & Chief Executive Officer,
Singapore Operations, Dr. Reddys
Laboratories, Singapore

15:30

Ken Wong, Deputy Director, MTech/

AP&T Extractables & Leachables,
Sanofi Pasteur, United States

Sponsored slot

Sponsored slot

Cold chain data management

Cellular immunotherapy manufacturing

facilities

Nyoman Mahardika, Director, South

Asia Supply Chain, Mead Johnson
Nutrition, Thailand

Xu Wei, Chief Operating Officer, Sotio,

China

Sponsored slot

Sponsored slot

15:50

Roundtable discussions
Table A: Risk assessment and exit
strategies for biotech investors

Table A: Process monitoring and

statistical process control

Table A: Improving clinical supply

importation and exportation

James Huang, Managing Partner,

Kleiner Perkins Caufield Byers
(KPCB), China

Pankaj Gour, Downstream Expert

MS&T, Novartis BiopharmOps,
Singapore

Edwin Sia, Associate Director,

Logistics, Asia Pacific, Quintiles,
Singapore

Table B: Partnership models for vaccine

development

Table B: Continuous downstream

processing

Table B: Pan-Asian clinical trials

coordination

Table B: Bioethics and patient safety

Table C: Partnership models for

biosimilars development

Table C: Preventing aggregation in

purification process

Table C: Adaptive trials design

Table C: Cell vs gene therapy

16:30

Afternoon refreshments I Exhibition visit I 1-to-1 partnering

17.40

17.20

17.00

QUALITY BY DESIGN (QbD)

18:00

Table A: Cost reductions via target

identification

Analytical Quality by Design (AQbD) methods

development using platform approach
Jianmei Kochling, Director, Quality Science and
Analytical Technology, Genzyme, USA

QbD: Risk-based vs non-QbD

CLINICAL DESIGN

Biomarkers for personalised medicine

TRANSLATIONAL MEDICINE

Cross-functional collaboration: Researchers and

clinicians

Clinical supply chain efficiency in emerging markets

Shiva Kapsi, Director, Emerging Markets, R&D,

GlaxoSmithKline, Singapore

Voo Jiunn Horng, Senior Manager, Clinical & Ancillary

Supply Services (CASS), Asia Pacific, Covance,
Singapore

Generation of variants in QbD

Holistic approaches for serialisation

James Sutter, BioProcess Sciences Downstream

Process, Merck, Switzerland

Pankaj Monga, Director, Brand Protection, Asia,

Janssen, India

Regulatory frameworks for translational medicine

Sponsored slot

Sponsored slot

Sponsored slot

18:20

End of conference day one I BioPharma Awards Dinner 2015

Bench-to-bedside techniques for drug development

Premium
Conference
08:45

Organisers welcome remarks

08:50

Chairmans opening address

09:00

09:30

The end of copycat China

Shaun Rein, Managing Director, China Market Research Group (CMR), China
Advancing Asias biopharmaceuticals industry
Christopher Gallen, President, SK Biopharmaceuticals, Korea
Speed networking

10:30

Morning refreshments I Exhibition visit I 1-to-1 partnering

11:00

10:00

TRACK 1

TRACK 2

TRACK 3

TRACK 4

ORPHAN DRUGS

BIOSIMILARS

REGULATIONS

COLD CHAIN

Pricing strategies for orphan drugs

Global regulatory compliance of QbD

strategies

Global biosimilars regulatory

compliance
May Wei, Global Regulatory Strategist,
Bayer Healthcare, China

Jun Matsumoto, Principal Reviewer,

Office of Cellular and Tissue-based
Products, Pharmaceutical and
Medical Devices Agency (PMDA),
Japan

Debashis Basu, Head, Supply Chain,

Roche Diagnostics, India

11:20

Patient access via industrial

collaboration

11:40

Anticipating temperature excursions

during regional transport through risk
management strategy

Gaining orphan drug designations in

Asia

Packaging and marketing for biosimilars

Koike Satoshi, Director, Regulatory

Affairs, Japan, Amgen Astellas
Biopharma KK, Japan

Cold chain models for vaccines in

pandemic outbreaks

12:00

Regulatory updates for trials in Asia

Qualified validation processes for cold

chain storage equipment

Sponsored slot

Sponsored slot

Sponsored slot

Sponsored slot

Bioethics and pricing of biosimilars

Victoria Elegant, Vice President,

Medical, Clinical, Regulatory Affairs,
Baxter International, China

Sanjit Singh Lamba, Managing

Director & President, Global Brands
Unit; Head, Global Procurement
Strategy, Eisai Knowledge Center,
India

IND submission and approval in Japan

Roundtable discussions

12:20

Table A: Patient recruitment &

retention strategies for orphan drug
trials

Table A: Translating biosimilar market

trends into sound production strategies
Atul Deshpande, Associate Director,
Unit Strategy Officer Asia Pacific TSU,
Sanofi, China

Table A: Approval processes in Japan,

Korea and Australia

Table B: Regulatory requirements for

biosimilars manufacturing
Table B: Patient outreach initiatives for
rare disease communities

Samuel Raj Solomon, Senior

Manager & Head, Biosimilars
International Regulatory Affairs,
Biocon, India

Table C: Reimbursement schemes for

orphan drugs in Asia

Table C: Biosimilar and biobetter

development

13:00

Networking luncheon I Exhibition visit I 1-to-1 partnering

Table B: Approval processes in China

and India

Table C: Approval processes in

Singapore and Malaysia
Shun Jin, Director, Regulatory Affairs,
Takeda Pharmaceuticals, Singapore

Table A: Creating an unbroken cold

chain
Debashis Basu, Head, Supply Chain,
Roche Diagnostics, India

Table B: Human error in cold chain

Shirley Xu, Head, Site Supply,
Novartis Vaccines, China

Table C: Demand forecast for cost

effective cold chain practices

Day Two
Wednesday 25 March 2015

14:50

14:30

LICENSING
Key elements in structuring effective
deals in China
Kathy Yu, Senior Director, Business
Development and Strategy, Merck
Serono, China

Bringing early stage clinical research

to Asia
James Garner, Head, Unit
Development Operations, Asia R&D,
Sanofi, Singapore

VACCINES

COMPLIANCE

Quality by Design (QbD) tools

for pandemic influenza vaccine
development
Pradip M Patel, Vice President &
Head, Vaccine (Operations & Project),
Zydus Cadila, India

Novel adjuvants for effective vaccine

development

15:30

15:10

Packaging your drugs for lucrative outlicensing deals

Nilesh Wadhwa, Regional Director,
Business Development & Strategy,
Takeda Pharmaceuticals,
Singapore

Clinical evaluation of vaccines

Audits and inspections in Asia-Pacific

Angeline Lau, Regional Manager,
Clinical & Medical Quality Operations,
Sanofi Pasteur, Singapore

Aligning supply chain strategies with

the EU GDP and Chinas GSP regulations

SUPPLY CHAIN MANAGEMENT

Supply chain segmentation

Sanjay Desai, Director, Supply Chain,
ThermoFisher Scientific, Singapore

Exploring biopharmaceutical supply

chain sustainability in Asia

Michael Lee, Vice President,

Operations, Lohmann, Taiwan

Au Yang Sian, Senior Manager

Planning & Deployment, Asia Pacific,
Baxter International, Singapore

Balancing costs and quality in

packaging

Realising flexible supply chain through

postponement strategy

Cedric Dubois, Head, China Industrial

Operations, Sanofi Pasteur, China

Rajesh Pednekar, Head, Distribution,

Pfizer, India

Ensuring subject safety and data quality

through risk-based monitoring (RBM)
Sponsored slot

Sponsored slot

Javed Rashid, Chief Scientific Officer

& Head, Medical (Pharmaceuticals),
Novartis, Singapore

Sponsored slot

Roundtable discussions

Table A: Efficient vaccine production

for lower costs

Table B: Out-licensing

Table B: Serialisation of vaccines for

quality assurance

Table B: Best GMP practices in Asia

Table C: Technology transfer

Table C: Flexible vaccine manufacturing

operations

Table C: Best GCP practices in Asia

15:50

Table A: In-licensing

16:30

Afternoon refreshments I Exhibition visit I 1-to-1 partnering

17:00

End of conference day two

Enjoy special discounts

when you book as a group
Call +65 6322 2701 for more information

Table A: Effective adverse events

reporting systems

Table A: The right pharmaceutical

supply chain model for Asia
Terence Eng, Manager, Regional
Demand & Supply Planning, Novartis,
Singapore
Table B: Managing 3PLs in a
complicated supply chain network
Shirley Xu, Head, Site Supply,
Novartis Vaccines, China
Table C: Lean supply chain
management

The earlier you book

the more you save.
Book online today at
www.terrapinn.com/biopharmaasia

Whos attending
Senior Research Technology Specialist, Downstream Processing
Group, Bioprocess Technology Institute

A*STAR

Singapore

Site Manager

Abbvie

Singapore

Regional Medical Operations Manager, Japan and Asia-Pacific

Abbvie

Singapore

Marketing Coordinator

Almac

USA

Chief Executive Officer

Alteogen

South Korea

Director

Barrington James

UK

Senior Manager, Planning & Deployment

Baxter

Singapore

Senior Manager, Quality Leadership Process (Operation

Excellence)

Baxter Bioscience

Singapore

Senior Manager, Planning & Deployment, Asia-Pacific

Baxter International

Singapore

Head, Supply Coordination, Asia-Pacific

Bayer HealthCare

Singapore

Vice President, R&D

Beijing Minhai Biotechnology

China

Chief Executive Officer

Benitec

Australia

Chief Executive Officer

Benitec Biopharma

Australia

Senior Manager and Head, Biosimilars International Regulatory

Affairs

Biocon

India

Manager, Quality Assurance

Biocon

India

Head, Clinical Operations, Regional Operative Unit of Southeast

Asia and South Korea

Boehringer Ingelheim

Singapore

Chairman

Bora Pharmaceuticals

Taiwan

Chief Executive Officer

CANbridge Life Sciences

China

Marketing and Customer Service Manager

Colder Products Company

Hong Kong

Senior Manager, Clinical & Ancillary Supply Services (CASS),

Asia Pacific

Covance

Singapore

Chief Scientific Officer

CuroNZ

New Zealand

Distinguished Scientist, Bioengineering Group

Development Centre for Biotechnology

Taiwan

Non-Executive Director and Former Chief Executive Officer

Dimerix Bioscience

Australia

Chief Executive Officer and Global Head, Technical Operations

Dr. Reddys Laboratories

Singapore

Managing Director and Head, Global Procurement Strategy

Eisai Knowledge Center; Eisai

Singapore

Senior Vice President, Asia-Pacific

eResearchTechnology

USA

Patent Examiner

European Patent Office

Austria

Chief Executive Officer

Galmed Pharmaceuticals

Israel

Regional Manager, Regulatory Affairs

Genzyme

Singapore

Director, Quality Science and Analytical Technology

Genzyme

USA

General Manager, Clinical Operations

GlaxoSmithKline

India

Chief Executive Officer

Gproan Protein Engineering

China

Vice President, Global Business Development and Marketing

Haselmeier GmBH

Germany

Consultant

Hays Life Sciences

Singapore

Managing Director

HepSeeVax

Australia

Co-Founder and Chief Executive Officer

HuaBo Biopharm

China

Chief Executive Officer

Huaota Biopharm

China

Marketing Manager, APAC

ICON Clinical Research

Singapore

Chief Executive Officer

ImmuOn Therapeutics

China

Executive Director

Imugene

Australia

General Manager, Distribution

Indchemie Health Specialities

India

Managing Director

Indus Biotech

India

Research Associate, Cell Line Development

Intas Biopharmaceuticals

India

Associate Director, R&D

Invictus Oncology

India

Business Development Manager

InVivos

Singapore

Director, Market Access & Government Affairs

Janssen

Malaysia

Director, Brand Protection, Asia

Johnson & Johnson

India

Chief Executive Officer

Kanghong Sagent (Chengdu) Pharmaceutical

China

Chief Executive Officer

Kaytee Bio

Japan

Vice President, Business Development

KBI Biopharma

USA

Chief Medical Officer & Senior Vice President, Clinical Research

KBP Biosciences

China

Vice President, Pharmacology

KBP Biosciences

China

Founder, President and Chairman

KBP Biosciences

China

Marketing Manager

LabCorp

USA

Vice President, Operations

Lohmann

Taiwan

Chief Executive Officer

MabSpace Biosciences

China

Managing Director

Mariposa Health

Australia

Director, South Asia Supply Chain

Mead Johnson Nutrition

Thailand

Director

Medigen

Taiwan

Associate Manager BioProcess Sciences, Downstream

Processing

Merck Serono

Switzerland

Director, Marketing Communications

MN Thermal Science

USA

Chief Executive Officer

NeuClone

Australia

President & Chief Executive Officer

Neupharma

China

Vice President, Discovery

Novalead Pharma

India

Manager, Regional Demand & Supply Planning

Novartis

Singapore

Senior Expert, Infrastructure and HVAC Site Services

Novartis

Singapore

Associate Manager, Clinical Distribution

Novartis

India

Project Director

Novartis Biopharm Ops

Singapore

Downstream Expert MS&T

Novartis BiopharmOps

Singapore

Head of Site Supply Chain

Novartis Vaccines

China

Clinical Research Manager

Novo Nordisk

Malaysia

Director, External Supply

Pfizer

India

Production Director

Pfizer

Singapore

Principal Reviewer, Office of Celluar and Tissue-based Products

Pharmaceuticals & Medical Devices Agency

(PMDA)

Japan

Chairman and Chief Executive Officer

Pluristem

Israel

Associate Director, Logistics, Asia-Pacific

Quintiles

Singapore

Director, Global Marketing

Quintiles

USA

Chief Executive Officer

Qurient Therapeutics

South Korea

Principal

ResearchDx

USA

Head, Supply Chain

Roche Diagnostics India

India

Director, Scientific

Rupert Myers Bldg

Australia

President

S.G. Research International

USA

Associate Director, Unit Strategy Officer, Asia Pacific TSU

Sanofi

China

Head, Unit Development Operations, Asia R&D

Sanofi

Singapore

Head, China Industrial Operations

Sanofi Pasteur

China

Regional Clinical Trial Manager

Sanofi Pasteur

Singapore

Deputy Director, Mtech/AP&T Extractables & Leachables

Sanofi Pasteur

USA

Head, Analytical Quality & Regulatory

SciGen BioPharma

India

Chief Executive Officer

Sentinext Therapeutics

Malaysia

Principal Investigator

Singapore Immunology Network (SIgN)

Singapore

President

SK Biopharmaceuticals

South Korea

Chief Operating Officer

Sotio

China

Chief Executive Officer

Starpharma

Australia

Principal Investigator

Stem Cell and Cancer Institute

Indonesia

Chief Executive Officer

Suzhou Connect Biopharmaceuticals

China

Director, Regulatory Affairs

Takeda Pharmaceuticals

Singapore

Chief Executive Officer

Tarrex Biopharma

China

Director, Supply Chain

ThermoFisher

Singapore

Director, Strategic Insight and Innovation

Toyota Financial Services

USA

Associate Project Manager

TTY Biopharm

Taiwan

Marketing and Communication Officer

Viroclinics Biosciences

Netherlands

Associate Vice President and Head, Legal

Wockhardt

India

Chief Financial Officer

Yisheng Biopharma

China

Vice President & Head, Vaccine (Operations & Project)

Zydus Cadila

India

Premium
Keynote

Tuesday 24 March 2015

10.00am

Making peoples lives better through

change, innovation & growth

David Gallon
Director, Strategic Insight &
Innovation
Toyota Financial Services, USA

Constantly striving to improve the world and lives of those around

him, Dave Gallon has grounded his career in continuous investigation,
analytical rigor, creative exploration, and inspirational leadership. During
his professional career, he has helped to transform education institutions
and corporate environments, as well as advancing the marketing,
planning and communications practices within the Toyota, Lexus and
Scions brands. He will leverage on his wealth of experience in marketing,
research, competitive intelligence, strategic planning, future trends, and
organisational innovation roles to share how the pharma industry can
improve to truly become innovative.

Freemium
conference

Day One
Tuesday 24, March 2015

Theatre One

Theatre Two

Facility and process design

Research Symposium

HVAC in good clean room design

11:00

Jogesh Bhole, Senior Expert, Infrastructure & HVAC, Site Services,

Novartis, Singapore

11:20

Uncovering the real value of Asias pharma industry

11:40

12:00

Applying continuous process verification in creating robust

biomanufacturing process
Vijay Nag Thota, Head, Analytical Quality & Regulatory, SciGen
BioPharma, India

Reaping manifold advantages from modular construction

Hosted by:
Singapore Immunology Network (SIgN)

12:20

Analytical challenges in cleaning validation for biologics manufacturing

Green manufacturing

12:40

Greening your pharma manufacturing practices, is it possible to balance

cost and sustainability?
Rajnish Narula, Director, Production, Pfizer, Singapore

1:00

Gearing towards sustainable manufacturing through cogeneration: the

success story of Biogen Idec

1:20

Single use or reusable facilities: Which is really greener?

1:40

Sustainable by design: A focus on waste treatment

Embracing different fields of study, the Biomedical Research Council

(BMRC) of Agency for Science, Technology and Research (A*STAR)
serves to strengthen the research community of Singapore. Singapore
Immunology Network (SIgN) was launched as a part of BMRC with the
purpose of advancing research in human immunology. Join researchers
and investigators of SIgN as they share their ground-breaking studies on
immunity against different prevalent diseases.

terrapinn.com/biopharmaasia

Theatre One

Theatre Two

Clinical trials in biosimilars & antibodies

Raw material procurement

2:00

Pre-clinical studies for antibody biosimilars

Building a successful outsourcing network by selecting the right supplier

2:20

Early stage clinical trials for antibody biosimilars

Sanjay Desai, Director, Supply Chain, ThermoFisher Scientific,

Singapore

2:40

Late phase clinical trials for antibody biosimilars

Sanjit Singh Lamba, Managing Director, Eisai Knowledge Center; Head,

Global Procurement, Eisai Pharmaceutical, India

3:00

Phase IV clinical trials for antibody biosimilars

The call for anticorruption effort for MNC procurement activities

Solving the puzzle in demand forecasting

Raw material procurement in India

Clinical trials in stem cells & regenerative medicine

Product Integrity and supply chain security

3:20

Clinical trials for diabetes

Cross industry applications: Ensuring product integrity during product

transportation

3:40

Clinical trials for degenerative neurology

Cross industry applications of techniques to prevent theft and counterfeiting.

4:00

Clinical trials for fetal stem cells research

Shipment security: Marine & air transportation

4:20

Clinical trials on stem cell therapies for heart disease

Product integrity during warehouse storage

4:40

Clinical trials on stem cell therapies for ultra rare diseases

Handling emergency cases when product integrity is compromised due to

mishandling

5:00

End of Day One

Freemium
conference

Day Two
Wednesday, 25 March 2015

09:00

09:20

Theatre One

Theatre Two

Clinical trials in vaccines

Warehousing and product distribution

Clinical trials for Malaria Vaccines

Hothousing the thermolabile product

Clinical trials for Influenza Vaccines

Best practices in stock handling during picking and preparing for delivery
day

Reserved for Viroclinics

Sagnik Sengupta, General Manager, Distribution, Bharat Serums and

Vaccines, India

09:40

Clinical trials for Hepatitis B Vaccines

Outsourcing decision: warehousing activities and inventory management

10:00

Clinical trials for HIV Vaccines

Optimise the use of IT and cloud technology in track and trace of products
during delivery

Clinical trials in Oncology

10:20

10:40

11:00

11:20

11:40

Clinical trials for lung cancer

Cold chain transportation in tropical countries

Michael Lee, Vice President, Operations, Lohmann, Taiwan

Clinical trials for chronic myeloid leukemia

Selecting the right 3PL in cold chain logistics

Reserved for Quintiles

Sanjay Desai, Director, Supply Chain, Thermo Fisher Scientific, Singapore

Clinical trials for head & neck cancer

Investigating ways to create flexible and agile distribution model in Asia

Case study: Can you get patent protection for personalized medicine in
Europe using PCT procedure?
Fredrik Aslund, Patent Examiner, European Patent Office, The
Netherlands

Clinical trials for cervical cancer

Smart packaging

Finding the best strategies for reaching consumers and product recall

terrapinn.com/biopharmaasia

12:00

Theatre One

Theatre Two

Quality Control

Research Symposium

Implementing Total quality management (TQM) in pharma manufacturing

process
Anjali Mahajan, Manager, Quality Assurance, Biocon, India

Optimising the manufacturing process with lean 6

12:20

Sankar Dharmaraj, Senior Manager, Quality Leadership Process (Operation

Excellence), Baxter Biosciences, Singapore

12:40

Uncovering the importance of raw material and its effect on final product
quality

1:00

Discovering various viral removal techniques from biologics product

Hosted by:

Automation

1:20

Leveraging on automated technology to optimise aseptic fill and finish

process

1:40

Maximising manufacturing capability by automated aseptic fill and finish

process

2:00

Are robots the solution for robust biologics manufacturing?

2:20

Man or machine? The balance between companys money and morale

2:40

3:00

Crafting the best facility for real time process monitoring

Rajnish Nawla, Director, Production, Pfizer, Singapore

End of Day Two

Stem Cell and Cancer Institute

Stem Cell and Cancer Institute (SCI), a division of Indonesias leading
pharmaceutical company, strives for novel clinical applications of umbilical
cord matrix as a source of mesenchymal stem cells. With a strong focus on
lung and breast cancer, SCIs cancer research has been the talk of town.
Recently, the Institute has held hands with a leading manufacturer of adult
allogeneic stem cells, Stemedica as the exclusive licensor to conduct clinical
trials in Indonesia. Hear what exciting research is in the way for Stem Cell
and Cancer Institute!

Premium
Keynote

Wednesday 25 March 2015

9.30am

Advancing Asias biopharmaceuticals

industry, implications, directions and
strategies

Dr. Christopher Gallen

President
SK Biopharmaceuticals,
South Korea

Dr. Christopher Gallen is an internationally recognised figure in the field of

clinical research. With more than 25 years of experience, his skills centre
on scientific strategic insights, to bring out the best in people and a strong
understanding of how to use processes integrated with appropriate
technologies to produce superior performance.

Freemium
conference
Day 1: Vaccines, Immunology
and Chronic Diseases

Vaccines and Immunology

Beijing Minhai Biotechnology, China

Chronic Diseases

MabSpace Biosciences, China

Xueming Qian, Chief Executive Officer

Wenjin Wei, Vice President (R&D)

KBP Biosciences, China

Sentinext Therapeutics, Malaysia
Li Long, Vice President, Pharmacology
David Lawrence, Chief Executive Officer
NovaLead Pharma, India
HepSeeVax, Australia
Sudhir Kulkarni, Vice President, Discovery
Serina Cucuzza, Managing Director

Mariposa Health Limited, Australia

ImmuOn Therapeutics, China

Philip Comans, Managing Director

John Wang, Chief Executive Officer

Indus Biotech, India

Sunil Bhaskaran, Managing Director

Imugene, Australia
Neuclone, Australia
Nick Ede, Executive Director
Noelle Sunstrom, Chief Executive Officer
Yisheng Biopharma, China

Dimerix Bioscience, Australia

David Shao, Chief Financial Officer

Gproan Protein Engineering, China

Haiqian An, Chief Executive Officer

James Williams, Non-Executive Director and

Former Chief Executive Officer
Suzhou Connect Biopharmaceuticals, China
Zheng Wei, Chief Executive Officer

terrapinn.com/biopharmaasia

Day1:2:Vaccines,
OncologyImmunology
and other
Day
Freemium
prevalent
diseases
in Asia
andconference
Chronic
Diseases
Day 2: Oncology and other
prevalent diseases in Asia

Oncology

TTY Biopharm, Taiwan

Lily Lien, Associate Project Manager

Benitec Biopharma, Australia

Alteogen, Korea
Peter French, Chief Executive Officer
Soon Jae Park, Chief Executive Officer
Huabo Biopharm, China
Bora Pharmaceuticals, Taiwan
Wenzhi Tian, Chief Executive Officer
Bobby Sheng, Chairman
Invictus Oncology, India
Starpharma, Australia
Monideepa Roy, Associate Director of R&D
Jackie Fairley, Chief Executive Officer
CANbridge Life Sciences, China
James Xue, Chief Executive Officer

Prevalent diseases in Asia

Qurient Therapeutics, Korea

CuroNZ, New Zealand
Kiyean Nam, Chief Executive Officer
Frank Sieg, Chief Scientific Officer
Tarrex Biopharma, China
Kaytee Bio, Japan
Kanyin Zhang, Chief Executive Officer
Kensei Tsuzaka, Chief Executive Officer
IMMD, Japan
Akiko Itai, Chief Executive Officer

Chengdu Kanghong Pharmaceuticals, China

Chen Su, Chief Executive Officer

NeuPharma, China

Pluristem, Israel

Shawn Qian, President & Chief Executive Officer

Zami Aberman, Chief Executive Officer

Medigen Biotechnology, Taiwan

Galmed Pharmaceuticals, Israel

Stanley Chang, Director

Allen Baharaff, Chief Executive Officer

Premium
Keynote

Wednesday 25 March 2015

9.00am

The end of
copycat China
Shaun Rein
Managing Director
China Market Research Group
(CMR) China

Shaun Rein is the Founder and Managing Director of the China Market
Research Group (CMR), the worlds leading strategic market intelligence
firm focused on China. He works with Fortune 500 and leading private
equity firms, SMEs, and hedge funds. He an internationally best-selling
author of The End of Cheap China and of upcoming The End of
Copycat China.
Rein is often featured in the Wall Street Journal, Fortune, and The
Financial Times. His op-eds have appeared in the New York Times, and
he frequently appears on MSNBC, CNBC, Bloomberg, BBC, and CNN.
He previously was a weekly columnist for CNBC and Forbes and also
used to write a regular column for Bloomberg BusinessWeek

Networking
Weve created ample opportunities for you to network with the other attendees at the
BioPharma Asia Convention; many of them are included in the premium conference agenda, but
you can join us at these additional activities as well.

Workshops
Join us the day before the main conference opens to get an in-depth
understanding of some of the industrys most pressing topics
Morning:
Positioning your R&D pipelines as
an attractive investment
Designing innovative clinical trials
Creating a sustainable
biomanufacturing plant with single
use technologies
Best practices in cold chain
management in Asia

Afternoon:
Achieving excellence in biologic
manufacturing with continuous
improvement
Pricing strategies for
biopharmaceuticals in emerging
markets
Clinical trials outsourcing in Asia
Using big data analysis to
streamline supply chain practices

23 March, 9.00am 5.30pm, Suntec Singapore Convention & Exhibition Centre

Welcome Cocktail Reception

Network with the other attendees over a complimentary cocktail. Get to know
the delegates youll be spending the next couple of days with and make some
initial introductions. This is open to all premium conference pass holders. RSVP
required
23 March, 7.00pm 8.30pm, Secret venue (confirmed upon registering as a
delegate)

Networking app
Download the networking app to get organised and get in touch with all
attendees months before the event begins
Use the Total BioPharma Portal to:
Plan your sessions
Build a personalised agenda
Identify exhibitors to visit
Set up onsite meetings with key executives
Network with other attendees

Keep your messages, meeting schedules and session agenda at your fingertips. You can continue to
use this networking tool for a full year after the event so you can follow up with anybody you missed
months down the line.
Contact us today on +65 6322 2770 to confirm your attendance at these networking activities and purchase premium
conference pass tickets

MARKET ACCESS

Pricing and
reimbursement
strategies in Japan,
Korea and Australia

Pricing and
reimbursement
strategies in
China and India

Pricing and
reimbursement
strategies in Singapore
and Malaysia

ORPHAN DRUGS

Patient recruitment
and retention strategies
for orphan drug trials

Patient outreach
initiatives for rare
disease communities

Reimbursement
schemes for orphan
drugs in Asia

CELL CULTURE

The roundtable discussions are an opportunity to

deliberation, guided by an expert

Hybrid manufacturing
for cell culture
production

Raw material
testing and handling

Decontamination
technologies for
cell culture growth

BIOSIMILARS

Roundtable
Discussions

Translating biosimilar
market trends into
sound production
strategies

Regulatory
requirements
for biosimilars
manufacturing

Biosimilar and
biobetter development

MERGER & ACQUISITION

Risk assessment and

exit strategies for
biotech investors

Partnership models
for vaccine
development

Partnership models
for biosimilars
development

LICENSING

In-licensing

Out-licensing

Technology
transfer

DOWNSTREAM
PROCESSING

Process monitoring
and statistical
process control

Continuous
downstream
processing

Preventing
aggregation in
purification process

VACCINES

gain an in-depth understanding of a topic through peer to peer debate and

t. This also doubles up as a natural networking opportunity.

Efficient vaccine
production for
lower costs

Serialisation of
vaccines for
quality assurance

Flexible vaccine
manufacturing
operations

CLINICAL DEVELOPMENT

Clinical outsourcing
models in Japan,
Korea and Australia

Clinical outsourcing
models in China
and India

Clinical outsourcing
models in Singapore
and Malaysia

REGULATIONS

Approval processes
in Japan, Korea and
Australia

Approval processes
in China and India

Approval processes
in Singapore
and Malaysia

GENERICS

Reverse logistics

CMO selection in Asia

Pricing of generics

COLD CHAIN

Roundtable
Discussions

Creating an unbroken
cold chain

Human error in
cold chain

Demand forecast for

cost effective cold
chain practices

DATA MANAGEMENT

Improving clinical
supply importation
and exportation

Pan-Asian clinical
trials coordination

Adaptive trials
design

COMPLIANCE

Effective adverse
events reporting
systems

Best GMP practices

in Asia

Best GCP practices

in Asia

CELL & GENE THERAPY

Cost reductions via

target identification

Bioethics and
patient safety

Cell vs gene therapy

SUPPLY CHAIN
MANAGEMENT

terrapinn.com/biopharmaasia

The right
pharmaceutical
supply chain model
for Asia

Managing 3PLs
in a complicated
supply chain network

Lean supply chain

management

The Exh

Get involved
Be seen as an initiator in BioPharma innovation
Take the stage to showcase your expertise in
front of a pool of prospects
Share your latest products and services to an
exhibition full of potential customers
PREMIUM
TRACK 4

Network! Rub shoulders with warm leads and

key clients across Asia

COUNTRY
PAVILION
C30

Secure a speaking slot in front of a receptive

audience of senior level decision makers in the
premium conference

A28

Pre-arrange 1-2-1 meetings with your preferred

client list
MR6

B27

A26

B25

A24

B23

MR7

C28

FREEMIUM
THEATRE 1

MR8

Who you will meet

MR4
MR3

MR2

NETWORKING
LOUNGE

CXOs from biotechs and SMEs

B18

C19

B16

C17

MR1

C10

Directors of the various biopharma verticals

For sponsorship and

exhibition opportunities,
please contact:
Kenneth Lai at +65 6322 2792,
kenneth.lai@terrapinn.com

ASIAN BIOTECH
SHOWCASE

D12

E11

D10

E09
E07

D11

C08

D07

D08

C04

D05

D04

PREMIUM
TRACK 3

Decision makers across the APAC biopharma

value chain

Decision influencers and industry stakeholders

of the APAC Biopharma Industry

GENIE
BAR

LOUNGE

CXOs from APAC biopharma brands

FREEMIUM
THEATRE 2

C26

C24

MR5

CXOs of APAC coming from international

biopharma brands

NETWORKING LU
& REFRESHM

SOLD

RESERVED

hibition

Be seen & heard

Secure your booth along the busy aisles to
generate maximum traffic
Present a case study at the pharma value chain
development seminars
Craft booth activities and leverage on our
marketing activities to increase your market
presence

NCHEON
ENTS

Host private luncheons, cocktails, seminars with

your pre-qualified guest list

PREMIUM
TRACK 1

COUNTRY
PAVILION

BIOPHARMA ASIA
INDUSTRY AWARDS
DINNER

F24

F20

G21

F18

G19

F16

G17

F14

G15

Lead roundtable discussions that show off your

expertise and industry knowledge

Who should sponsor &

exhibit

E10

E08

E02

Contract service providers (CROs, CMOs,

CDMOs)

F11

F07

PREMIUM
TRACK 2

G07

E03

F04

F05

F02

F03

Clinical research solution providers

eClinical trials and big data management
solutions providers

H02

H03

Manufacturing solution providers (upstream,

downstream)
Facility HVAC, cleanroom and containment
equipment providers
Country governments / trade agencies
Legal and compliance firms
Consultants and banks
3rd party logistics providers
Cold chain packaging companies
Distributors in Asia Pacific
Executive search firms
Laboratory equipment providers

The BioPharma Asia Opportunity

Youve got goals? We can help you achieve them. The opportunity to brand and market yourself is like none
other at the BioPharma Asia Convention 2015. Work out your business priorities and let us craft a strategy that
puts your brand out in front of the Asia Pacific biopharmaceutical industry.
Engage with potential clients

Generate leads, leads and more leads!

Exhibit at the show

Market your whitepaper with Total BioPharma

Work out a visitor campaign with us

Leverage on lead generation activities

Host a dedicated closed door workshop to

reach your target audience

Network with potential clients without fighting

your competitors at a private luncheons

Lead a roundtable discussion, hear industry

issues and present your solutions

Utilise the networking app and our networking activities

Brand your company and products

Be a thought leader and educator

Leverage on our social media channels to expand

your networks

Join a panel or moderate during discussion platforms

Write an e-book that promotes your industry

knowledge

Take up premium slots in the Total BioPharma

newsletter and gain maximum outreach through
our database

Get involved in our new product, latest launch ideas

Lead an interactive clinic within the conference agenda

Brand activities within the event that are aligned with your
companys direction

Share a case study and discuss trends as a speaker

Benefits

Diamond

Platinum

Gold

Silver

Bronze

Exhibitor

Plenary forum moderator

1 day

Plenary presentation slot

1 x 20 mins

Networking socials sponsor

Private hospitality benefits

(private luncheon & cocktail sponsorship)

Yes

Yes

Lead generation via content E-book

Design and execute interactive value

chain clinic

Lead generation via social media

campaign

Host roundtable session

Onfloor value chain speaking sessions

Onsite and event marketing logo branding

Diamond

Platinum

Gold

Silver

Bronze

Exhibitor

Exhibition booth

36 sqm

24 sqm

18 sqm

12sqm

9sqm

9sqm

VIP Passes for company representatives

10

Passes to exhibition

10

VIP Passes for clients

15

10

Access to networking app

Unlimited

Unlimited

Unlimited

Unlimited

Unlimited

Unlimited

Price (SGD)

85,000 and
above

65,000
80,000

40,000
60,000

28,000
35,000

18,000
25,000

10,000
15,000

Contact Kenneth Lai to discuss sponsorship & exhibition opportunities on +65 6322 2792 or Kenneth.lai@terrapinn.com

The BioPharma Asia Facts

Who attends?

Pharma

Biotech

RI

CRO

CMO

Government

Consultant

Hospital

Investor

Where from?

Europe

Asia

17%
of the Wo
st

rld

Re

68%
5%
Australia

USA

3%

7%

Contact Kenneth Lai on +65 6322 2792 or

Kenneth.lai@terrapinn.com to find out how
you can best profile your company at Asias
leading regional biopharma event.

2000
+
800
+
600
+
30
+
15
2
3

Industry
stakeholders
1-to-1
meetings
C-level
executives
Hours of
networking
Conference
brands
Research
symposiums
On-floor seminar
sessions

The BioPharma series

For decades, Terrapinn has been hosting BioPharma Conventions across the globe.
Leading international pharmaceutical and biotech companies as well as notable
industry figures have participated as keynote speakers and delegates across the
various conference agendas. These events have received the endorsement of long
established societies and associations and the support of some of the industrys
biggest service providers. The BioPharma Conventions are highly prestigious
amongst industry professionals.

21-23 October 2014,

Seoul Renaissance Hotel,
Seoul, South Korea

4-5 November 2014,

Mexico City, Mexico

10-11 November 2014,

The Lalit Mumbai, India

23-25 March 2015,

Suntec Singapore Convention &
Exhibition Centre, Singapore

Special discounts are available when booking for multiple events at one time. Call +65 6322 2770 to find out more

The BioPharma Asia

Industry Awards
Innovate. Impact. Inspire.
The 5th Biopharma Asia Industry Awards dinner celebrates 10 organisations/individuals for their
contributions and achievements to Asias burgeoning biologics industry.
Join over 250 biopharma A-listers at this years BioPharma Asia industry awards evening,
which promises to be a starry affair indeed.

ve
ati
ov ch
n
In ote
Bi

ng
i
s
ni
g
co he
e
t
R
st
e
B

Asia
Mal n
Exe e
c

an
Asi an
m
o
W ec
Ex

CR

CMO

LS

P
ld
Co ain
Ch

Up
So str
lu eam
tio
n

am
tre
ns ion
w
Do olut
S

Pharma

The award categories are:

CRO
CMO
LSP
Cold Chain Packaging Solution Provider
Upstream Manufacturing Solution Provider

Downstream Manufacturing Solution Provider

Innovative Biotech
Outstanding Pharma
Asian Male Executive
Asian Woman Executive

Nominate an organisation that deserves to be recognised for their efforts to better Asias biopharma industry.
Nominations close on 17 October 2014. Tickets can be purchased with your conference pass registration.
7.00pm 9.30pm, 24 March 2015,
Suntec Singapore Convention & Exhibition Centre
Contact Kenneth Lai at +65 6322 2792 or kenneth.lai@terrapinn.com
www.terrapinn.com/bio-asia/awards

Reserve your place today

The earlier you book the more youll save.
Its really easy to book your place online.
And our online calculator will ensure
you take advantage of the best deal.
Go and book now on
www.terrapinn.com/biopharmaasia
Dont forget to enter special code PM01
to claim the Early Bird discount.

Currency shown in SGD

Register now and get the offer price on your phone
Scan this QR pattern with the camera
on your smartphone and register with a
discount code PM01 at the special offer
price.
Dont have a QR reader app? You can
download one for free from App Store.
Dont have a smartphone? You can also
register and get the offer on our website
www.terrapinn.com/biopharmaasia

Standard Rate
Before 17 Oct 14

Final Price

2 Day Pass

2,695

2,995

3 Day Pass

3,595

3,995

Pharma/Biotech Rate
Before 17 Oct 14

Final Price

2 Day Pass

1,615

1,975

3 Day Pass

2,155

2,635

Academic Rate

BOOK NOW
Go to
www.terrapinn.com/biopharmaasia
and book with a
special discount code PM01
Or call +65 6322 2770

Before 17 Oct 14

Final Price

2 Day Pass

810

900

3 Day Pass

1,080

1,200

BRING YOUR TEAM

Theres so much great content, you cant possibly
cover it all alone!
Bring your team and get an extra discount. There are
special group packages available call +65 6322 2770
for more information.

Sponsors & Exhibitors

Silver Sponsors

Bronze Sponsors

knows your target

Exhibitors